Abiomed Inc. a leading provider of break-through heart support technologies today announced the successful first human use of the Impella cVADTM device a new percutaneous Impella heart pump that provides peak flow of approximately 4 liters of blood per minute.
System to deliver painkillers has history of malfunctions report finds. Hundreds of patients across the country have been injured using the kind of self-operated medication pumps involved in three recent incidents at St. Luke's Hospital.
Ann Arbor-based Terumo Heart Inc. a wholly owned subsidiary of Japan's Terumo Corp. Tuesday announced that a patient implanted with the DuraHeart Left Ventricular Assist System has surpassed five years of support on the mechanical circulatory support device.
ANN ARBOR Michigan July 19 2011 /PRNewswire/ Terumo Heart Inc. a wholly owned subsidiary of Terumo Corporation today announced that a patient implanted with the DuraHeart(TM) Left Ventricular Assist System (LVAS) has surpassed five